{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T08:21:02Z","timestamp":1790151662219,"version":"4.0.1"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100013700","name":"National Comprehensive Cancer Network","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.ajo.2025.03.032","type":"journal-article","created":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T12:29:26Z","timestamp":1743251366000},"page":"30-39","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"special_numbering":"C","title":["Incidence and Prevalence of Uveitis and Associated Ocular Complications in the United States TriNetX Database"],"prefix":"10.1016","volume":"276","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-3885-2739","authenticated-orcid":false,"given":"NILA","family":"KIRUPAHARAN","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"RAYNA F.","family":"MARSHALL","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-6201-1060","authenticated-orcid":false,"given":"MATTHEW D.","family":"SPANGLER","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9381-4756","authenticated-orcid":false,"given":"KAREN R.","family":"ARMBRUST","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7517-7706","authenticated-orcid":false,"given":"MEGHAN K.","family":"BERKENSTOCK","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.ajo.2025.03.032_bib0001","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1136\/bjo.80.9.844","article-title":"The possible impact of uveitis in blindness: a literature survey","volume":"80","author":"Suttorp-Schulten","year":"1996","journal-title":"Br J Ophthalmol"},{"issue":"9","key":"10.1016\/j.ajo.2025.03.032_bib0002","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1136\/bjo.2003.037226","article-title":"Degree, duration, and causes of visual loss in uveitis","volume":"88","author":"Durrani","year":"2004","journal-title":"Br J Ophthalmol"},{"issue":"8","key":"10.1016\/j.ajo.2025.03.032_bib0003","doi-asserted-by":"crossref","DOI":"10.1111\/eci.13572","article-title":"Immunopathophysiology and clinical impact of uveitis in inflammatory rheumatic diseases: an update","volume":"51","author":"Hysa","year":"2021","journal-title":"Eur J Clin Invest"},{"issue":"2","key":"10.1016\/j.ajo.2025.03.032_bib0004","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/BF00942778","article-title":"Classification of 750 consecutive uveitis patients in the Rotterdam eye hospital","volume":"17","author":"Smit","year":"1993","journal-title":"Int Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2025.03.032_bib0005","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1076\/opep.9.4.239.1507","article-title":"Causes of uveitis at the eye center in Saudi Arabia: a retrospective review","volume":"9","author":"Islam","year":"2002","journal-title":"Ophthalmic Epidemiol"},{"issue":"3","key":"10.1016\/j.ajo.2025.03.032_bib0006","doi-asserted-by":"crossref","first-page":"173","DOI":"10.4103\/0301-4738.31936","article-title":"Global variation and pattern changes in epidemiology of uveitis","volume":"55","author":"Rathinam","year":"2007","journal-title":"Indian J Ophthalmol"},{"issue":"6","key":"10.1016\/j.ajo.2025.03.032_bib0007","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.ajo.2008.09.014","article-title":"Incidence and prevalence of uveitis in Veterans affairs medical centers of the pacific northwest","volume":"146","author":"Suhler","year":"2008","journal-title":"Am J Ophthalmol"},{"issue":"11","key":"10.1016\/j.ajo.2025.03.032_bib0008","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1001\/jamaophthalmol.2013.4237","article-title":"Incidence and prevalence of uveitis: results from the Pacific Ocular Inflammation Study","volume":"131","author":"Acharya","year":"2013","journal-title":"JAMA Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajo.2025.03.032_bib0009","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.ophtha.2003.06.014","article-title":"Incidence and prevalence of uveitis in Northern California; the Northern California Epidemiology of Uveitis Study","volume":"111","author":"Gritz","year":"2004","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2025.03.032_bib0010","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1001\/archopht.1962.00960030506014","article-title":"Epidemiology of uveitis. Incidence and prevalence in a small urban community","volume":"68","author":"Darrell","year":"1962","journal-title":"Arch Ophthalmol"},{"issue":"11","key":"10.1016\/j.ajo.2025.03.032_bib0011","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1001\/jamaophthalmol.2016.3229","article-title":"Prevalence of noninfectious uveitis in the United States: a claims-based analysis","volume":"134","author":"Thorne","year":"2016","journal-title":"JAMA Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2025.03.032_bib0012","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1080\/09273948.2021.1988113","article-title":"Epidemiology of Uveitis in Olmsted County, Minnesota: A Population-Based Follow-Up Study","volume":"31","author":"Xu","year":"2023","journal-title":"Ocul Immunol Inflamm"},{"issue":"3","key":"10.1016\/j.ajo.2025.03.032_bib0013","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/eye.2015.269","article-title":"Visual outcomes and ocular morbidity of patients with uveitis referred to a tertiary center during first year of follow-up","volume":"30","author":"Groen","year":"2016","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.ajo.2025.03.032_bib0014","series-title":"Health Insurance Portability and Accountability Act of 1996","year":"1996"},{"key":"10.1016\/j.ajo.2025.03.032_bib0015","unstructured":"United States Census Bureau. https:\/\/www.census.gov\/quickfacts\/fact\/table\/US\/PST045221"},{"issue":"6","key":"10.1016\/j.ajo.2025.03.032_bib0016","doi-asserted-by":"crossref","DOI":"10.2196\/17174","article-title":"Evaluating the representativeness of US centricity electronic medical records with reports from the centers for disease control and prevention: comparative study on office visits and cardiometabolic conditions","volume":"8","author":"Montvida","year":"2020","journal-title":"JMIR Med Inform"},{"key":"10.1016\/j.ajo.2025.03.032_bib0017","doi-asserted-by":"crossref","DOI":"10.1016\/j.coi.2022.102266","article-title":"The increasing prevalence of autoimmunity and autoimmune diseases: an urgent call to action for improved understanding, diagnosis, treatment, and prevention","volume":"80","author":"Miller","year":"2023","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.ajo.2025.03.032_bib0018","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.613893","article-title":"Association between air pollution and the risk of uveitis: a nationwide, population-based cohort study","volume":"12","author":"Bai","year":"2021","journal-title":"Front Immunol"},{"issue":"5","key":"10.1016\/j.ajo.2025.03.032_bib0019","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1159\/000518496","article-title":"Immune-mediated uveitis and lifestyle factors: a review","volume":"64","author":"Guo","year":"2021","journal-title":"Ophthalmic Res"},{"issue":"6","key":"10.1016\/j.ajo.2025.03.032_bib0020","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/j.ophtha.2015.02.034","article-title":"Association between smoking and uveitis: results from the pacific ocular inflammation study","volume":"122","author":"Yuen","year":"2015","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2025.03.032_bib0021","article-title":"Advances in imaging of uveitis","volume":"12","author":"Marchese","year":"2020","journal-title":"Ther Adv Ophthalmol"},{"issue":"6","key":"10.1016\/j.ajo.2025.03.032_bib0022","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1001\/jamaophthalmol.2020.2004","article-title":"Ophthalmology after coronavirus disease 2019 (COVID-19): transition back to patient care","volume":"138","author":"Parke","year":"2020","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.ajo.2025.03.032_bib0023","article-title":"The impact of COVID-19 pandemic on ophthalmology services: are we ready for the aftermath?","volume":"12","author":"Ting","year":"2020","journal-title":"Ther Adv Ophthalmol"},{"issue":"6","key":"10.1016\/j.ajo.2025.03.032_bib0024","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1080\/09273948.2019.1687733","article-title":"Visual acuity outcome over time in non-infectious uveitis","volume":"29","author":"Pistilli","year":"2021","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.ajo.2025.03.032_bib0025","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.2147\/OPTH.S89428","article-title":"Intermediate uveitis, posterior uveitis, and panuveitis in the Mid-Atlantic USA","volume":"9","author":"Engelhard","year":"2015","journal-title":"Clin Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2025.03.032_bib0026","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/00005792-200107000-00005","article-title":"Chronic severe uveitis: etiology and visual outcome in 927 patients from a single center","volume":"80","author":"Bodaghi","year":"2001","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"10.1016\/j.ajo.2025.03.032_bib0027","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ophtha.2017.08.007","article-title":"Immunosuppression for the uveitides","volume":"125","author":"Jabs","year":"2018","journal-title":"Ophthalmology"},{"issue":"10","key":"10.1016\/j.ajo.2025.03.032_bib0028","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1016\/j.ophtha.2008.04.026","article-title":"Comparison of antimetabolite drugs as corticosteroid-sparing therapy for noninfectious ocular inflammation","volume":"115","author":"Galor","year":"2008","journal-title":"Ophthalmology"},{"issue":"6","key":"10.1016\/j.ajo.2025.03.032_bib0029","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/S0161-6420(01)00576-0","article-title":"Methotrexate therapy for chronic noninfectious uveitis: analysis of a case series of 160 patients","volume":"108","author":"Samson","year":"2001","journal-title":"Ophthalmology"},{"issue":"12","key":"10.1016\/j.ajo.2025.03.032_bib0030","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1001\/jamaophthalmol.2019.3964","article-title":"Antimetabolite therapy for uveitis: methotrexate or mycophenolate?","volume":"137","author":"Jabs","year":"2019","journal-title":"JAMA Ophthalmology"},{"issue":"4","key":"10.1016\/j.ajo.2025.03.032_bib0031","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1080\/17469899.2017.1319762","article-title":"Comparative efficacy of steroid-sparing therapies for non-infectious uveitis","volume":"12","author":"Knickelbein","year":"2017","journal-title":"Expert Rev Ophthalmol"},{"key":"10.1016\/j.ajo.2025.03.032_bib0032","doi-asserted-by":"crossref","first-page":"2997","DOI":"10.2147\/DDDT.S94188","article-title":"Profile of adalimumab and its potential in the treatment of uveitis","volume":"10","author":"Balevic","year":"2016","journal-title":"Drug Des Devel Ther"},{"issue":"3","key":"10.1016\/j.ajo.2025.03.032_bib0033","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.ophtha.2013.09.048","article-title":"Expert panel recommendations for the use of anti-tumor necrosis factor biologic agents in patients with ocular inflammatory disorders","volume":"121","author":"Levy-Clarke","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2025.03.032_bib0034","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/1750-1172-7-57","article-title":"Uveitis- a rare disease often associated with systemic diseases and infections- a systematic review of 2619 patients","volume":"7","author":"Barisani-Asenbauer","year":"2012","journal-title":"Orphanet J Rare Dis"},{"issue":"6","key":"10.1016\/j.ajo.2025.03.032_bib0035","article-title":"Noninfectious uveitis in rheumatology: patterns, treatment, and outcomes","volume":"15","author":"Younus","year":"2023","journal-title":"Cureus"},{"issue":"9","key":"10.1016\/j.ajo.2025.03.032_bib0036","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12093194","article-title":"Sarcoidosis-related uveitis: a review","volume":"12","author":"Giorgiutti","year":"2023","journal-title":"J Clin Med."}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939425001576?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939425001576?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T10:45:34Z","timestamp":1762080334000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939425001576"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":36,"alternative-id":["S0002939425001576"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2025.03.032","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Incidence and Prevalence of Uveitis and Associated Ocular Complications in the United States TriNetX Database","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2025.03.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}